GENE ONLINE|News &
Opinion
Blog

DNA
R&D Cancer Therapy
Why CRY2 matters: Studying Control of Plants and Human Growth
2022-06-20
R&D DNA
Antitumor Response of Left-handed Z-DNA Reinvigorates Immunotherapy’s Efficacy
2022-06-02
R&D DNA
New Kind of Cell Division Without DNA Replication
2022-05-12
Technology Gene EditingCRISPR
TALED Tool Launches a New Era of Mitochondrial Genome Editing
2022-05-03
Special Single Cell Sequencing
Single Cell Sequencing Uncovers How Early Embryonic Cells Differentiate
2022-04-13
Innovation Human Genome
Researchers Have Now Identified the Complete Human Genome without Any Gaps
2022-04-06
Interviews Children
Sudden Death in Infants Could Have a Genetic Basis
2022-03-29
COVID-19 Vaccine
Scientists Work On an Oral Vaccine Booster for COVID-19
2022-01-07
Innovation CRISPR
Harnessing the potential of CRISPR-Cas9 for Gut Microbiome Gene Editing
2021-11-29
R&D CRISPR
Using Electricity and CRISPR, Scientists Enable Inheritable Data Storage on Bacterial DNA
2021-01-24
DNA Amplification
Tokyo-Based Genomics Company Launches World’s First Cell-Free DNA Amplification Process
2020-10-04
Deals Gene Editing
Novartis Enters $75 Million Collaboration with Sangamo for its Zinc Finger Gene Editing Technology
2020-08-01
R&D DNA Synthesis
Codexis, Molecular Assemblies Enter Revolutionary DNA Synthesis Partnership
2020-07-08
Technology RNA Sequencing
Proximity RNA Sequencing: Breaking New Grounds in Spatial Transcriptomics
2020-06-28
Gene Therapy
Weekly Top 5 in China (0317-0323)
2019-03-25
1 2 3
LATEST
Ascletis Announces U.S. IND Filing of Oral RdRp Inhibitor Drug Candidate ASC10 for COVID-19
2022-07-05
Breakthrough Zebrafish Genome Database Now Available
2022-07-05
WuXi Biologics Adds Microbial Fermentation to CDMO Offering in Hangzhou
2022-07-05
Sanofi Launches Nonprofit Brand To Distribute Medicines to Low-Income Countries
2022-07-05
As Private Equity Sale Becomes Less Likely, Novartis May Gravitate Towards Sandoz Spinoff
2022-07-04
Ascletis Begins Study of PD-L1 Antibody Candidate Against HIV
2022-07-04
Akebia Therapeutics Gains $55M Following Deal Termination by Otsuka Pharmaceutical
2022-07-04
READ MORE
EVENT
2022-07-27
BIO Asia–Taiwan 2022
Online and on-side
2022-08-03
BIOPLUS-INTERPHEX KOREA
Seoul
2022-09-09
ESMO 2022 Exhibition
Online and on-side
2022-09-21
CSCO Educational Book 2022
Xiamen
2022-09-21
RESI Boston
Boston
2022-09-26
Human Gene Therapy Conference
Australia
SEE MORE
Newsletter
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2022 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top